NAROPIN 0.2% ropivacaine hydrochloride 20mg/10mL injection ampoule

Aspen Pharmacare Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: ddad278502ef34a8
Product Name: NAROPIN 0.2% ropivacaine hydrochloride 20mg/10mL injection ampoule
Artg Id: 52406
Artg Name: NAROPIN 0.2% ropivacaine hydrochloride 20mg/10mL injection ampoule
Sponsor: Aspen Pharmacare Australia Pty Ltd
Company Detail Path: /organization/aspen-pharmacare-australia-pty-ltd
Artg Date: 1996-01-30
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2017-CMI-01875-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2017-PI-01874-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

ddad278502ef34a8

Type

Standard